Lexaria Bioscience Corp.
NASDAQ: LEXX
Healthcare
Biotechnology
Global Rank
#43023
Country Rank
#1649
Market Cap
9.06 M
Price
5.48
Change (%)
2.49%
Volume
72,231
Lexaria Bioscience Corp.'s latest marketcap:
9.06 M
As of 08/06/2026, Lexaria Bioscience Corp.'s market capitalization has reached $9.06 M. According to our data, Lexaria Bioscience Corp. is the 43023th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 9.06 M |
| Revenue (ttm) | 194,000 |
| Net Income (ttm) | -7,732,026 |
| Shares Out | 1.65 M |
| EPS (ttm) | -5.14 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/13/2026 |
Market Cap Chart
Data Updated: 08/06/2026
Lexaria Bioscience Corp.'s yearly market capitalization.
Lexaria Bioscience Corp. has seen its market value drop from $18.9 M to $9.06 M since 2007, representing a total decrease of 52.09% and an annual compound decline rate (CAGR) of 3.88%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/06/2026 | $9.06 M | 9.64% | 43023 |
| 12/31/2025 | $13.7 M | -62.67% | 35574 |
| 12/31/2024 | $36.7 M | 186.72% | 30122 |
| 12/29/2023 | $12.8 M | -12.33% | 36004 |
| 12/30/2022 | $14.6 M | -36.8% | 34251 |
| 12/31/2021 | $23.1 M | 2.67% | 31994 |
| 12/31/2020 | $22.5 M | -24.75% | 28957 |
| 12/31/2019 | $29.9 M | -58.3% | 24581 |
| 12/31/2018 | $71.7 M | -38.87% | 19036 |
| 12/29/2017 | $117.3 M | 624.07% | 17168 |
Company Profile
Lexaria Bioscience Corp. was founded in 2004 in Canada.
on the Nasdaq Stock Market.
With 7 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Lexaria Bioscience Corp.'s (LEXX) current market cap?As of 08/06/2026, Lexaria Bioscience Corp. (including the parent company, if applicable) has an estimated market capitalization of $9.06 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Lexaria Bioscience Corp. (LEXX) rank globally by market cap?Lexaria Bioscience Corp. global market capitalization ranking is approximately 43023 as of 08/06/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.